Phase 1 Study of SL-325 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL

SL-325

DR3 blocking antibody

OTHER

Placebo (Normal Saline)

Normal saline

Trial Locations (1)

RECRUITING

Celerion, Lincoln

All Listed Sponsors

lead

Shattuck Labs, Inc.

INDUSTRY

NCT07158437 - Phase 1 Study of SL-325 in Healthy Volunteers | Biotech Hunter | Biotech Hunter